CpG-Based Nanovaccines for Cancer Immunotherapy
Wenqiang Chen,1 Mingxia Jiang,1 Wenjing Yu,1 Zhiwei Xu,1 Xinyue Liu,1 Qingmiao Jia,1 Xiuwen Guan,1– 3 Weifen Zhang1– 3 1College of Pharmacy, Weifang Medical University, Weifang, 261053, People’s Republic of China; 2Collaborative Innovation Center for Target Drug Delivery System, Weifang Medical Univ...
Saved in:
Main Authors: | Chen W, Jiang M, Yu W, Xu Z, Liu X, Jia Q, Guan X, Zhang W |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/347926a805d042829941f9b4fa3a92a9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
by: Dong Y, et al.
Published: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice
by: Zhao Y, et al.
Published: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
by: Zhao Y, et al.
Published: (2021) -
Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens
by: Lin SY, et al.
Published: (2020) -
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
by: Ting Cai, et al.
Published: (2021)